3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

March 29, 2002

Primary Completion Date

January 20, 2003

Conditions
HIV Infections
Interventions
DRUG

Tipranavir

Trial Locations (62)

Unknown

Boehringer Ingelheim Investigational Site, Phoenix

Boehringer Ingelheim Investigational Site, Fountain Valley

Living Hope Clinical Trials, Inc., Long Beach

Boehringer Ingelheim Investigational Site, Los Angeles

David Geffen School of Medicine at UCLA, Los Angeles

Vincent Lombardi Cancer Center, Washington D.C.

Therafirst Medical Center, Fort Lauderdale

1501 N.W. 9th Ave, Miami

Boehringer Ingelheim Investigational Site, Orlando

Boehringer Ingelheim Investigational Site, South Miami

Hillsborough County Health Dept., Tampa

Boehringer Ingelheim Investigational Site, Vero Beach

Boehringer Ingelheim Investigational Site, Atlanta

Atlanta VA Medical Center, Decatur

Mercer University School of Medicine, Macon

CORE Center, Chicago

Rush-Presbytarian-St Luke's Medical Center, Chicago

University of Louisville, Louisville

HIV Outpatient Program (H.O.P), New Orleans

John's Hopkins University, Baltimore

Boehringer Ingelheim Investigational Site, Boston

Community Research Initiative of New England, Springfield

University of Michigan Health System, Ann Arbor

Boehringer Ingelheim Investigational Site, Kansas City

Washington University, St Louis

Boehringer Ingelheim Investigational Site, Las Vegas

ID Care, Hillsborough

Boehringer Ingelheim Investigational Site, Santa Fe

Albany Medical College, Albany

University of New York at Stony Brook, Stony Brook

Duke University Medical Center, Durham

Boehringer Ingelheim Investigational Site, Huntersville

Wake Forest University Baptist Medical Center, Winston-Salem

Ohio State University Medical Center, Columbus

Boehringer Ingelheim Investigational Site, Oklahoma City

Boehringer Ingelheim Investigational Site, Columbia

Boehringer Ingelheim Investigational Site, Houston

Boehringer Ingelheim Investigational Site, Annandale

Boehringer Ingelheim Investigational Site, Darlinghurst

St. Vincent's Hospital, Darlinghurst

Boehringer Ingelheim Investigational Site, Ottawa

Toronto General Hospital, Toronto

Montreal Chest Institute - McGill University Health Centre, Montreal

Hôpital de Bicêtre, Le Kremlin-Bicêtre

Hôpital de Chauliac, Montpellier

Hôpital Hôtel Dieu, Nantes

Hôpital Bichat Claude Bernard, Paris

Hôpital de la pitié Salpetrière, Paris

Hôpital Saint Louis, Paris

Epimed GmbH, Berlin

Klinik I für Innere Medizin der, Cologne

Klinikum der J.-W.-Goethe-Universität, Frankfurt am Main

Medizinische Poliklinik, München

Fondazione Centro S. Raffaele del Monte Tabor, Milan

IRCCS Policlinico San Matteo, Pavia

Academisch Medisch Centrum, Amsterdam

Erasmus Medical Centre, Rotterdam

Hospital Clínico y Provincial de Barcelona - HIV, Barcelona

Boehringer Ingelheim Investigational Site, Madrid

Hospital La Paz., Madrid

Hospital Ramón y Cajal., Madrid

4th Floor Research Office (St Stephens Centre), London

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY